KLRA · Kailera Therapeutics, Inc.
Market Cap
$2.10B
Shares
129.64M
Kailera Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Kailera Therapeutics, Inc. (KLRA), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Earnings call
FY26 · Q2
2026-08-12
Kailera Therapeutics, Inc. (KLRA) Q2 2026 Earnings Call
Diluted EPS
$-1.09
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-04
Kailera Therapeutics, Inc. (KLRA) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-26
Kailera Therapeutics, Inc. (KLRA) Q1 2026 Earnings Call
Diluted EPS
$-3650.00
Audio
Transcript
Slides
8-K10-Q
Showing 1–3 of 3 earnings calls
Key facts
CIK
2096997
CUSIP
482931102
13F (30d)
92 filings
90 filers
Visit website
Investor relations